Compare Jones Lang LaSalle Inc (JLL) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jones Lang LaSalle Inc vs Teladoc Health Inc — how do they compare? Jones Lang LaSalle Inc trades at $329.03 (market cap $15.12B), while Teladoc Health Inc trades at $9.8 (market cap $1.74B). The key difference: Jones Lang LaSalle Inc is far larger — about 8.7× Teladoc Health Inc's market cap, and Teladoc Health Inc is trading nearer its 52-week high, Jones Lang LaSalle Inc nearer its low. Which is the better fit depends on your goals.
| JLL | TDOC | |
|---|---|---|
Market Cap | $15.12B | $1.74B |
Sector | Real Estate | Health |
52-Week High | $358.66 | $9.72 |
52-Week Low | $253.48 | $4.47 |
Enterprise Value | $18.66B | $2.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JLL trades at $325.94, down 1.43% today, but maintains a bullish technical outlook with strong moving average signals. The company shows solid fundamental improvement with revenue growing from $20.9B in 2022 to $26.1B in 2025, while net income margin expanded to 3.35%. Recent earnings beats and positive analyst coverage (54.55% buy rating) support the stock's upward trajectory, with a consensus price target of $405.50 representing 24.4% upside potential.
JLL presents a compelling investment case with improving profitability, strong cash flow generation ($1.19B operating cash flow in 2025), and positive business momentum in commercial real estate services. Key risks include exposure to commercial real estate cycles and potential economic slowdowns, but the company's debt-to-asset ratio improvement to 9.32% and consistent earnings beats provide fundamental support for continued growth.
TDOC trades at $9.63, up 2.12% today, with a bullish technical signal from moving averages and a neutral RSI near 60. Revenue remains stable around $2.5 billion, but net losses persist with a -6.81% margin. Recent news highlights expansion through the Walmart partnership and upcoming Q2 2026 earnings. The stock shows resilience despite negative profitability, supported by a low P/S ratio of 0.67 and improving cash flow trends from operations.
Outlook is mixed: cost-cutting and partnerships offer growth potential, but sustained losses and high debt pose risks. Analysts are cautious with a $8.75 price target below current levels, reflecting concerns over profitability. Investors should weigh the recovery narrative against financial challenges, with earnings on July 29, 2026, as a key catalyst.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jones Lang LaSalle Inc
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.
Read more on JLL →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
